Doximity Inc (NYSE: DOCS)’s stock price has gone rise by 2.53 in comparison to its previous close of 42.35, however, the company has experienced a 4.02% increase in its stock price over the last five trading days. investors.com reported 2024-10-31 that This telehealth technology provider is holding above its 50-day moving average. The company reports its next earnings on Nov. 7.
Is It Worth Investing in Doximity Inc (NYSE: DOCS) Right Now?
Doximity Inc (NYSE: DOCS) has a higher price-to-earnings ratio of 54.60x compared to its average ratio. DOCS has 36-month beta value of 1.29. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 3 as “overweight,” 11 as “hold,” and 2 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for DOCS is 120.56M, and currently, short sellers hold a 8.63% ratio of that float. The average trading volume of DOCS on November 07, 2024 was 1.69M shares.
DOCS’s Market Performance
The stock of Doximity Inc (DOCS) has seen a 4.02% increase in the past week, with a -1.32% drop in the past month, and a 21.97% gain in the past quarter. The volatility ratio for the week is 2.48%, and the volatility levels for the past 30 days are at 2.41% for DOCS. The simple moving average for the past 20 days is 2.52% for DOCS’s stock, with a 38.66% simple moving average for the past 200 days.
Analysts’ Opinion of DOCS
Many brokerage firms have already submitted their reports for DOCS stocks, with Barclays repeating the rating for DOCS by listing it as a “Overweight.” The predicted price for DOCS in the upcoming period, according to Barclays is $52 based on the research report published on October 15, 2024 of the current year 2024.
Needham, on the other hand, stated in their research note that they expect to see DOCS reach a price target of $38. The rating they have provided for DOCS stocks is “Buy” according to the report published on August 09th, 2024.
Wells Fargo gave a rating of “Underweight” to DOCS, setting the target price at $19 in the report published on July 18th of the current year.
DOCS Trading at 5.58% from the 50-Day Moving Average
After a stumble in the market that brought DOCS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.25% of loss for the given period.
Volatility was left at 2.41%, however, over the last 30 days, the volatility rate increased by 2.48%, as shares surge +0.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +18.95% upper at present.
During the last 5 trading sessions, DOCS rose by +4.07%, which changed the moving average for the period of 200-days by +46.16% in comparison to the 20-day moving average, which settled at $42.35. In addition, Doximity Inc saw 54.85% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DOCS starting from Wampler Kira Scherer, who sale 2,500 shares at the price of $42.00 back on Nov 01 ’24. After this action, Wampler Kira Scherer now owns 16,618 shares of Doximity Inc, valued at $105,000 using the latest closing price.
Cabral Timothy S, the Director of Doximity Inc, sale 20,000 shares at $42.07 during a trade that took place back on Nov 01 ’24, which means that Cabral Timothy S is holding 11,074 shares at $841,306 based on the most recent closing price.
Stock Fundamentals for DOCS
Current profitability levels for the company are sitting at:
- 0.37 for the present operating margin
- 0.9 for the gross margin
The net margin for Doximity Inc stands at 0.33. The total capital return value is set at 0.19. Equity return is now at value 16.86, with 14.42 for asset returns.
Based on Doximity Inc (DOCS), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at 12.1.
Currently, EBITDA for the company is 182.08 million with net debt to EBITDA at -0.47. When we switch over and look at the enterprise to sales, we see a ratio of 16.2. The receivables turnover for the company is 3.86for trailing twelve months and the total asset turnover is 0.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.69.
Conclusion
To put it simply, Doximity Inc (DOCS) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
